The Her Option™ Cryoablation Therapy System (CG-1) is a closed-cycle cryosurgical device designed for in-office endometrial ablation. It utilizes sub-zero temperatures to destroy the endometrial lining of the uterus, providing a minimally invasive, non-hormonal treatment for pre-menopausal women suffering from menorrhagia (excessive uterine bleeding) due to benign causes and who have completed childbearing. The system is engineered specifically for office-based use, offering patient comfort, a strong safety profile, and a short total treatment time. Most patients can return to normal activities within a day, and the procedure requires only minimal anesthesia without the need for IV sedation or surgery.

Key Features:

• Closed-cycle cryosurgical device: Uses extreme cold (–100 to –120°C at the probe tip) to ablate the endometrial lining.
• Office-based procedure: Designed for use in a clinic setting, not requiring hospital admission or general anesthesia.
• Short treatment and recovery time: Typical procedure lasts 20–25 minutes, with most patients resuming normal activities within hours.
• High patient satisfaction: Studies show a 94% effectiveness rate in reducing bleeding, with 20–25% of patients achieving amenorrhea (no periods).
• No hormones or surgery required: Provides an alternative to hormone therapy and surgical ablation.
• Minimal anesthesia: Most cases require only local anesthesia; IV sedation is not necessary.
• Strong safety profile: Low rates of perioperative and postoperative pain and complications.
• Contraindications: Not for use in patients who are pregnant, desire future fertility, or have known/suspected endometrial carcinoma or active genital infection.
• Components: Includes a console (compressor system, user interface, microprocessor), cryoprobe, and a single-use disposable control unit that covers the cryoprobe during use.